Keyphrases
Acute Lymphoblastic Leukemia
100%
Molecular Mechanism
100%
Genetic Susceptibility
100%
ARID5B
100%
Leukemia Risk
33%
Risk Variant
25%
Myocyte Enhancer Factor 2C (MEF2C)
25%
Cis-regulatory Elements
25%
UK Biobank
16%
Lymphocyte Count
16%
Non-coding
16%
Enhancer Element
8%
High-throughput
8%
Targeted Sequencing
8%
Gene Locus
8%
Co-immunoprecipitation (co-IP)
8%
Genome-wide Association Study
8%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
8%
Variant Allele
8%
Childhood Acute Lymphoblastic Leukemia
8%
Functional Impact
8%
Common Variants
8%
Chromatin Immunoprecipitation (ChIP)
8%
Leukemogenesis
8%
Non-acute
8%
Statistical Test
8%
Germline DNA
8%
Runt-related Transcription Factor 1 (RUNX1)
8%
Acute Lymphoblastic Leukemia Cells
8%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
8%
Transcription Factor Binding
8%
Binding Motif
8%
UK10K
8%
Additive Model
8%
DCas9-KRAB
8%
Hematological Traits
8%
Strong Enhancer
8%
Transcription Factor Complex
8%
Exact Functional
8%
Interference System
8%
Biochemistry, Genetics and Molecular Biology
Enhancer Region
100%
Genetic Susceptibility
100%
Regulatory Sequence
75%
MEF2C
75%
Transcription Factors
50%
Promoter Region
25%
B Cell
25%
Allele
25%
Germline
25%
Germ Cell
25%
Genome-Wide Association Study
25%
CRISPR
25%
Gene Locus
25%
Chromatin Immunoprecipitation
25%
Statistical Test
25%
RUNX1
25%
Sequence Motif
25%
Lymphocyte
25%